Recommandé pour les patients à risque modéré à élevé selon la classification EPUAP. Compatible avec les supports de lit médicalisés.
Rejoindre le programme d’affiliation

- Decubi : une solution cliniquement fondée pour la prévention des escarres.
Recommandé pour les patients à risque modéré à élevé selon la classification EPUAP. Compatible avec les protocoles aSSKINg et les supports de lit médicalisés. Sans alimentation électrique. Sans configuration.
Réduction de 56% du taux d’escarres — évaluation multisite

6 500h de temps soignant libéré en 12 mois
Voir les données cliniques
Trusted Nationwide and Widely Adopted
- Over 100k Users
- Covered by Health Plans
- 100+ VA Medical Centers
- Recommended by 1000+ Clinicians
Contact Us at Any Time
Recognized Excellence
Mom’s Choice Award 2020
Products Awards 2025
Global Recognition Award 2025
Spring Digital Health Awards 2025
CES Innovation Award 2025
Best Mental Health Technology 2024
Parents’ Picks Award 2025
Parents’ Picks Award 2024

Une solution médicale complète pour vos patients
Le matelas Decubi repose sur 3 technologies complémentaires pour protéger la peau des patients en immobilisation prolongée.
1. Structure bi-couche
Deux couches de mousse à densités différentes pour une protection optimale
- Prévention certifiée jusqu’au stade III (EPUAP)
- Distribution homogène de la pression corporelle
- Épouse la morphologie du patient
- Préserve sa forme dans le temps

2. Canaux de ventilation
Un système de ventilation intégré pour réguler température et humidité
- Circulation d’air continue sous le patient
- Régulation de la température cutanée
- Contrôle de l’humidité — facteur clé anti-escarres
- Confort optimal en immobilisation prolongée

3. Housse médicale OEKO-TEX®
Une housse certifiée, lavable et autoclavable pour respecter les protocoles d’hygiène
- Imperméable et antibactérienne
- Lavable en machine à 95°C
- Autoclavable à 121°C
- Se retire en secondes — protocoles hygiène respectés

4. Compatible tous environnements
Sans électricité, sans configuration — utilisable partout, immédiatement
- Compatible tous lits médicalisés réglables et inclinables
- Sans alimentation électrique — zéro configuration
- Utilisable à domicile ou en établissement

Deux couches de mousse à densités différentes pour une protection optimale
- Prévention certifiée jusqu’au stade III (EPUAP)
- Distribution homogène de la pression corporelle
- Épouse la morphologie du patient
- Préserve sa forme dans le temps

Un système de ventilation intégré pour réguler température et humidité
- Circulation d’air continue sous le patient
- Régulation de la température cutanée
- Contrôle de l’humidité — facteur clé anti-escarres
- Confort optimal en immobilisation prolongée

Une housse certifiée, lavable et autoclavable pour respecter les protocoles d’hygiène
- Imperméable et antibactérienne
- Lavable en machine à 95°C
- Autoclavable à 121°C
- Se retire en secondes — protocoles hygiène respectés

Sans électricité, sans configuration — utilisable partout, immédiatement
- Compatible tous lits médicalisés réglables et inclinables
- Sans alimentation électrique — zéro configuration
- Utilisable à domicile ou en établissement

Pourquoi les soignants choisissent le matelas Decubi
Une surface de support médicale passive, certifiée EPUAP, adaptée à tous les environnements de soins.
-
Prévention certifiée EPUAP stade III
Efficace pour les patients à risque modéré à élevé sans nécessiter de prescription spécifique -
Compatible protocoles aSSKINg
S’intègre naturellement dans les plans de soins existants sans modifier les routines -
Sans alimentation électrique
Aucune configuration, aucune maintenance — idéal pour les soins à domicile -
Housse autoclavable 121°C
Stérilisation complète entre chaque patient — protocoles d’hygiène pleinement respectés -
Livraison directe chez le patient
Commande en ligne, livré sous vide en 5 jours ouvrés partout en Europe -
Facture mutuelle fournie
Document officiel inclus avec chaque commande pour remboursement simplifié
- Résultats attendus:
- Situation aiguë:
Recommandé pour les patients alités en immobilisation prolongée, à risque modéré à élevé selon la classification EPUAP, présentant des zones de pression sur les proéminences osseuses. - Prévention continue:
L’utilisation d’une surface de support adaptée dès les premiers signes de risque a démontré une réduction jusqu’à 56% du taux d’escarres, une diminution du temps soignant et une amélioration du confort patient sur le long terme.

Profils de patients
Personne âgée à mobilité réduite
Patient alité longue durée
Convalescent post-opératoire
Patient en soins palliatifs
Personne en situation de handicap
Patient bariatrique
Patient Profiles
Why Is CalmiGo the Right Choice?

Medication Anxiolytics
Medical Devices
Medical Devices
Time to Relief (TTR)
3 minutes
15–30 minutes
37 days
10–15 minutes
(after weeks of practice)
Time to Calm Index (TTCI)
No Side Effects
No prescription required
0.0557
0.00108
0.0048
0.005
Long-Term Efficacy
Clinically Proven
Immediate Relief Within 3 Min
Suitable for Everyone
Useful in Acute Situations
Unlimited Customer Support

What Your Patients Receive
- CalmiGo Device and Accessories
- CalmiGo Device and Accessories
- Free Training Consultation
- Unlimited Support from our Specialized Team
Product Specs
What Your Patients Receive
Materials: BPA-free, food-grade plastic
Dimensions: 3.9 X 5.9 X 3.2 inches
Weight: 7.16 ounces
Assembly: Assembled in the USA
*CalmiGo’s battery compartment is closed with a screw, and a screwdriver is provided. If you cannot use a screwdriver, please reach out, so we can assist.
What Your Patients Receive
Materials: BPA-free, food-grade plastic
Dimensions: 3.9 X 5.9 X 3.2 inches
Weight: 7.16 ounces
Assembly: Assembled in the USA
*CalmiGo’s battery compartment is closed with a screw, and a screwdriver is provided. If you cannot use a screwdriver, please reach out, so we can assist.
Real Reviews from Real Customers
208 Reviews
Clinicians Testimonials

« This is the first tool that really works for clients who suffer from stress and anxiety and is drug-free »
Dr. Gigi Hamilton
Ph.D., LCMHC-S, NCC
A Licensed Psychotherapist

« CalmiGo is a drug-free adaptive breathing device. It uses sensory feedback to help you regulate your breathing and prolong your exhalation so that you can calm yourself down. »
Dr. Melissa Shepard Psychiatrist

« I would recommend doing that, if you are struggling with anxiety because doing so you can actually train your breath to regulate itself and as a result you get a more relaxed nervous system. »
Julia Tsakalis LCSW

« I would recommend doing that, if you are struggling with anxiety because doing so you can actually train your breath to regulate itself and as a result you get a more relaxed nervous system. »
Julia Tsakalis LCSW

« What I like about this is it’s drug free so it has no undesired side effects and it takes effect within minutes. »
Jonathan Decker LMFT
FAQ
How to integrate CalmiGo into patient care?
CalmiGo is a clinically validated, drug-free tool that helps patients manage anxiety, PTSD, panic attacks, and stress. Clinicians can integrate it into treatment plans as an accessible, non-pharmacological solution that complements existing therapies. With customizable features, real-time feedback, and adaptive strategies, CalmiGo evolves alongside patients’ needs, promoting lasting mental health improvements. It offers a scalable, user-friendly solution that supports both immediate relief and long-term resilience, enhancing patient outcomes without the need for medication.
How long do patients need to use the device to feel the effects?
For optimal results, each session with CalmiGo should be at least 3 minutes to achieve the desired exhalation prolongation. As a non-pharmacological intervention, patients can use the device for longer durations as needed, providing flexibility for individualized care during each session.
How will my patients know how to use this?
CalmiGo includes a user manual and an in-app video tutorial. We also offer a free training consultation with one of our specialists, which includes a personalized plan to help each individual integrate CalmiGo into their daily life
How do you use CalmiGo for best results?
Clinical studies support the proactive use of CalmiGo for long-term results, with 2–3 sessions per day, each lasting about three minutes. We also recommend using CalmiGo during acute situations for immediate relief. In the personalized training call, we work with patients to tailor usage to their individual needs and daily routines. As a non-pharmacologic tool, CalmiGo can be used as often as needed throughout the day without risk.
Is CalmiGo FDA-approved?
CalmiGo is classified as a “Low Risk Wellness Device” based on the FDA regulations. We are following the FDA guidelines for low-risk wellness devices.
What are the contraindications?
There are no known side effects, contraindications, or interactions with CalmiGo.
How do the scented plates enhance the CalmiGo experience?
CalmiGo uses organic, non-GMO, and vegan essential oils, such as lavender, to stimulate the limbic system, directly linked to emotional processing and memory. Lavender, known for its calming properties, helps reduce sympathetic nervous system activity, lowers stress biomarkers, and induce relaxation, making it highly effective during episodes of anxiety, panic, or PTSD.
Is this evidence-based?
CalmiGo integrates three scientifically supported methods to provide a comprehensive, non-pharmacological solution for managing anxiety, PTSD, and stress-related symptoms. By combining personalized breathing regulation, grounding through multi-sensory stimulation, and calming scents, CalmiGo offers both immediate relief and long-term emotional regulation.
Has the device been used in clinical trials?
CalmiGo has been rigorously tested in multiple independent clinical trials, demonstrating significant reductions in symptoms of anxiety, PTSD, stress, worry, and burnout. These studies support CalmiGo’s effectiveness as a drug-free tool for managing acute psychological distress, with evidence showing improvements in overall psychological well-being and emotional regulation.
Is there medication in the device?
CalmiGo offers a unique, non-pharmacological solution with zero medication, providing patients with an effective alternative for managing anxiety, panic, and PTSD symptoms. This approach eliminates the risks associated with pharmaceutical treatments, such as adverse side effects or dependency. Additionally, CalmiG has no known side effects, making it suitable for long-term use without the complications often seen with traditional medications. CalmiGo offers a safe, evidence-based tool that can be seamlessly integrated into patient care, providing clinicians with a reliable adjunct to traditional therapies while minimizing the risks associated with pharmacological interventions.
How does the CalmiGo device facilitate grounding?
Grounding occurs through multi-sensory stimulation. CalmiGo engages four senses—sight, sound, touch, and smell—simultaneously to create a holistic grounding experience. Visual feedback through lights, tactile sensations through vibration, calming scents, and auditory cues all work in tandem to reduce anxiety and promote a calm, centered state. This approach supports immediate emotional regulation and enhances long-term resilience.
CalmiGo is a clinically validated, drug-free tool that helps patients manage anxiety, PTSD, panic attacks, and stress. Clinicians can integrate it into treatment plans as an accessible, non-pharmacological solution that complements existing therapies. With customizable features, real-time feedback, and adaptive strategies, CalmiGo evolves alongside patients’ needs, promoting lasting mental health improvements. It offers a scalable, user-friendly solution that supports both immediate relief and long-term resilience, enhancing patient outcomes without the need for medication.For optimal results, each session with CalmiGo should be at least 3 minutes to achieve the desired exhalation prolongation. As a non-pharmacological intervention, patients can use the device for longer durations as needed, providing flexibility for individualized care during each session.
CalmiGo includes a user manual and an in-app video tutorial. We also offer a free training consultation with one of our specialists, which includes a personalized plan to help each individual integrate CalmiGo into their daily life
Clinical studies support the proactive use of CalmiGo for long-term results, with 2–3 sessions per day, each lasting about three minutes. We also recommend using CalmiGo during acute situations for immediate relief. In the personalized training call, we work with patients to tailor usage to their individual needs and daily routines. As a non-pharmacologic tool, CalmiGo can be used as often as needed throughout the day without risk.
CalmiGo is classified as a “Low Risk Wellness Device” based on the FDA regulations. We are following the FDA guidelines for low-risk wellness devices.There are no known side effects, contraindications, or interactions with CalmiGo.
CalmiGo uses organic, non-GMO, and vegan essential oils, such as lavender, to stimulate the limbic system, directly linked to emotional processing and memory. Lavender, known for its calming properties, helps reduce sympathetic nervous system activity, lowers stress biomarkers, and induce relaxation, making it highly effective during episodes of anxiety, panic, or PTSD.
CalmiGo integrates three scientifically supported methods to provide a comprehensive, non-pharmacological solution for managing anxiety, PTSD, and stress-related symptoms. By combining personalized breathing regulation, grounding through multi-sensory stimulation, and calming scents, CalmiGo offers both immediate relief and long-term emotional regulation.
CalmiGo has been rigorously tested in multiple independent clinical trials, demonstrating significant reductions in symptoms of anxiety, PTSD, stress, worry, and burnout. These studies support CalmiGo’s effectiveness as a drug-free tool for managing acute psychological distress, with evidence showing improvements in overall psychological well-being and emotional regulation.
CalmiGo offers a unique, non-pharmacological solution with zero medication, providing patients with an effective alternative for managing anxiety, panic, and PTSD symptoms. This approach eliminates the risks associated with pharmaceutical treatments, such as adverse side effects or dependency. Additionally, CalmiG has no known side effects, making it suitable for long-term use without the complications often seen with traditional medications. CalmiGo offers a safe, evidence-based tool that can be seamlessly integrated into patient care, providing clinicians with a reliable adjunct to traditional therapies while minimizing the risks associated with pharmacological interventions.
Grounding occurs through multi-sensory stimulation. CalmiGo engages four senses—sight, sound, touch, and smell—simultaneously to create a holistic grounding experience. Visual feedback through lights, tactile sensations through vibration, calming scents, and auditory cues all work in tandem to reduce anxiety and promote a calm, centered state. This approach supports immediate emotional regulation and enhances long-term resilience.







